Login to Your Account

Two-Day Tysabri Hearing Drawing Intense Attention

By Aaron Lorenzo

Monday, March 6, 2006
WASHINGTON - Tysabri could be coming back, at least in a limited capacity. That’s the growing consensus among many industry observers about the once heralded multiple sclerosis drug, which was pulled from the market a year ago after it was linked to a pair of deaths. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription